Sažetak sa skupa
Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report
Ivana Kampić
Željka Popijač
Puni tekst: hrvatski pdf 4.550 Kb
str. 126-127
preuzimanja: 323
citiraj
APA 6th Edition
Kampić, I. i Popijač, Ž. (2018). Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report. Medicinski vjesnik, 50 ((Suppl. 1)), 126-127. Preuzeto s https://hrcak.srce.hr/200768
MLA 8th Edition
Kampić, Ivana i Željka Popijač. "Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report." Medicinski vjesnik, vol. 50, br. (Suppl. 1), 2018, str. 126-127. https://hrcak.srce.hr/200768. Citirano 04.12.2024.
Chicago 17th Edition
Kampić, Ivana i Željka Popijač. "Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report." Medicinski vjesnik 50, br. (Suppl. 1) (2018): 126-127. https://hrcak.srce.hr/200768
Harvard
Kampić, I., i Popijač, Ž. (2018). 'Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report', Medicinski vjesnik, 50((Suppl. 1)), str. 126-127. Preuzeto s: https://hrcak.srce.hr/200768 (Datum pristupa: 04.12.2024.)
Vancouver
Kampić I, Popijač Ž. Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report. Medicinski vjesnik [Internet]. 2018 [pristupljeno 04.12.2024.];50((Suppl. 1)):126-127. Dostupno na: https://hrcak.srce.hr/200768
IEEE
I. Kampić i Ž. Popijač, "Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report", Medicinski vjesnik, vol.50, br. (Suppl. 1), str. 126-127, 2018. [Online]. Dostupno na: https://hrcak.srce.hr/200768. [Citirano: 04.12.2024.]
Puni tekst: engleski pdf 4.550 Kb
str. 126-127
preuzimanja: 108
citiraj
APA 6th Edition
Kampić, I. i Popijač, Ž. (2018). Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report. Medicinski vjesnik, 50 ((Suppl. 1)), 126-127. Preuzeto s https://hrcak.srce.hr/200768
MLA 8th Edition
Kampić, Ivana i Željka Popijač. "Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report." Medicinski vjesnik, vol. 50, br. (Suppl. 1), 2018, str. 126-127. https://hrcak.srce.hr/200768. Citirano 04.12.2024.
Chicago 17th Edition
Kampić, Ivana i Željka Popijač. "Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report." Medicinski vjesnik 50, br. (Suppl. 1) (2018): 126-127. https://hrcak.srce.hr/200768
Harvard
Kampić, I., i Popijač, Ž. (2018). 'Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report', Medicinski vjesnik, 50((Suppl. 1)), str. 126-127. Preuzeto s: https://hrcak.srce.hr/200768 (Datum pristupa: 04.12.2024.)
Vancouver
Kampić I, Popijač Ž. Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report. Medicinski vjesnik [Internet]. 2018 [pristupljeno 04.12.2024.];50((Suppl. 1)):126-127. Dostupno na: https://hrcak.srce.hr/200768
IEEE
I. Kampić i Ž. Popijač, "Application of alemtuzumab therapy in patients suffering from multiple sclerosis : a case report", Medicinski vjesnik, vol.50, br. (Suppl. 1), str. 126-127, 2018. [Online]. Dostupno na: https://hrcak.srce.hr/200768. [Citirano: 04.12.2024.]
Sažetak
Ključne riječi
Multiple sclerosis, Alemtuzumab; Healthcare; Education
Hrčak ID:
200768
URI
https://hrcak.srce.hr/200768
Datum izdavanja:
7.5.2018.
Podaci na drugim jezicima:
hrvatski
Posjeta: 1.424
*
